| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.0006 |